Jefferies analysts said Moderna’s first quarter was “in line,” with a miss on revenue offset by a beat on earnings per share.

From STAT’s Jason Mast: Moderna said this morning in its earnings report it planned to cut costs by around $1.5 billion by ...

Kennedy Jr. pushed discredited claims that the measles, mumps, and rubella (MMR) vaccine contains "a lot of aborted fetus ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

Several current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...

Public health experts worry the policy change would not only cast doubt on the safety and effectiveness of vaccines but would limit production and access. Separately, a decades-long pursuit of ...

UB researchers have compiled a list of words physicians should never say to patients with complex, chronic disorders that are ...

According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

How have the wild initial months of Donald Trump’s return to the White House landed on Washington? We asked the people who ...

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

Moderna Inc. said it will reduce annual spending by about $1.5 billion by 2027 as the company continues to cut costs to ...